$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Analysis of the effects and potential effects of taking one tablet of crizotinib daily
2026-02-01 22:25:32
Check Details
Do I need to stop taking crizotinib first when replacing brigatinib?
2026-02-01 22:25:32
Check Details
The use of targeted drug crizotinib for lung adenocarcinoma
2026-02-01 22:25:32
Check Details
The pharmacological mechanism of ritexitinib
2026-02-01 22:25:32
Check Details
Can ritexitinib cure alopecia areata?
2026-02-01 22:25:32
Check Details
How long do I need to take ritexitinib?
2026-02-01 22:25:32
Check Details
How long does it take to stop taking ritexitinib?
2026-02-01 22:25:32
Check Details
Can ritexitinib treat vitiligo?
2026-02-01 22:25:32
Check Details
Will hair loss continue after stopping ritexitinib?
2026-02-01 22:25:32
Check Details
How effective is ritexitinib in treating alopecia areata?
2026-02-01 22:25:32
Check Details
Dosage, usage and precautions for patients with ritexitinib
2026-02-01 22:25:32
Check Details
Brief description of instructions for use of Bangladeshi version of baricitinib generic drug
2026-02-01 22:25:32
Check Details
1
2
...
1076
1077
1078
1079
1080
1081
1082
...
10223
10224
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Axitinib: Indications, Mechanism of Action & Key Safety Warnings
2
Cabergoline Explained: Mechanism, Four Key Warnings & Dosing Guide
3
Capmatinib Generic Guide: Laos Version Availability, Efficacy & Safety Overview
4
Eltrombopag Administration Timing and Alternative Therapy Guide
5
Osimertinib Safety Guide: Foods to Avoid, Mechanism of Action, and Pre-Treatment Warnings
6
Avatrombopag: A Complete Guide to Dosage, Mechanism, and Clinical Use
7
Tazemetostat Dosage Guide: Laos Generic vs. Original Tazverik Comparison
8
Tivozanib: A Next-Generation Highly Selective VEGFR-Targeted Therapy Explained
9
Capmatinib Clinical Guide: Drug Comparisons, Treatment Strategies, and Combination Therapy Prospects
10
Avatrombopag Complete Guide: Efficacy, Indications, and TPO-RA Drug Comparisons
11
Pralsetinib Clinical Guide: Discontinuation Principles, Drug Comparisons, and Treatment Strategies
12
Venetoclax Clinical Guide: Mechanism, Indications, and Originator vs. Generic Comparison